139 related articles for article (PubMed ID: 23756577)
21. Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides.
Brockunier LL; Parmee ER; Ok HO; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Tota L; Wyvratt MJ; Fisher MH; Weber AE
Bioorg Med Chem Lett; 2000 Sep; 10(18):2111-4. PubMed ID: 10999482
[TBL] [Abstract][Full Text] [Related]
22. Differential involvement of caveolin-1 in brown adipocyte signaling: impaired beta3-adrenergic, but unaffected LPA, PDGF and EGF receptor signaling.
Mattsson CL; Andersson ER; Nedergaard J
Biochim Biophys Acta; 2010 Aug; 1803(8):983-9. PubMed ID: 20381543
[TBL] [Abstract][Full Text] [Related]
23. Functional BK channels facilitate the β3-adrenoceptor agonist-mediated relaxation of nerve-evoked contractions in rat urinary bladder smooth muscle isolated strips.
Afeli SA; Petkov GV
Eur J Pharmacol; 2013 Jul; 711(1-3):50-6. PubMed ID: 23643998
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys.
Hatanaka T; Ukai M; Watanabe M; Someya A; Ohtake A; Suzuki M; Ueshima K; Sato S; Masuda N
Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):1001-8. PubMed ID: 23832377
[TBL] [Abstract][Full Text] [Related]
25. Agonist effects of zinterol at the mouse and human beta(3)-adrenoceptor.
Hutchinson DS; Chernogubova E; Sato M; Summers RJ; Bengtsson T
Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):158-68. PubMed ID: 16601951
[TBL] [Abstract][Full Text] [Related]
26. Functional domains of the mouse beta3-adrenoceptor associated with differential G protein coupling.
Sato M; Hutchinson DS; Bengtsson T; Floren A; Langel U; Horinouchi T; Evans BA; Summers RJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1354-61. PubMed ID: 16144970
[TBL] [Abstract][Full Text] [Related]
27. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
[TBL] [Abstract][Full Text] [Related]
28. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
29. Activation of beta3 adrenergic receptor decreases DNA synthesis in human skin fibroblasts via cyclic GMP/nitric oxide pathway.
Furlán C; Sterin-Borda L; Borda E
Cell Physiol Biochem; 2005; 16(4-6):175-82. PubMed ID: 16301818
[TBL] [Abstract][Full Text] [Related]
30. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
Salie R; Alsalhin AKH; Marais E; Lochner A
Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome.
Igawa Y; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2013 Mar; 386(3):177-83. PubMed ID: 23263450
[TBL] [Abstract][Full Text] [Related]
32. Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.
Maruyama I; Goi Y; Tatemichi S; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):845-52. PubMed ID: 22552730
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
Yang Q; Battistini B; Pelletier S; Sirois P
Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
[TBL] [Abstract][Full Text] [Related]
34. BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via β
Mukaida S; Sato M; Öberg AI; Dehvari N; Olsen JM; Kocan M; Halls ML; Merlin J; Sandström AL; Csikasz RI; Evans BA; Summers RJ; Hutchinson DS; Bengtsson T
Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R666-R677. PubMed ID: 30892909
[TBL] [Abstract][Full Text] [Related]
35. Re: a functional analysis of the influence of β3-adrenoceptors on the rat micturition cycle.
Atala A
J Urol; 2014 Jul; 192(1):275-6. PubMed ID: 25629129
[No Abstract] [Full Text] [Related]
36. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
Shi ST; Li YF; Guo YQ; Wang ZH
J Cardiovasc Pharmacol; 2014 Nov; 64(5):407-11. PubMed ID: 24979391
[TBL] [Abstract][Full Text] [Related]
37. Molecular and functional characteristics of β3-adrenoceptors in late pregnant mouse uterus: a comparison with β2-adrenoceptors.
Parida S; Uttam Singh T; Ravi Prakash V; Mishra SK
Eur J Pharmacol; 2013 Jan; 700(1-3):74-9. PubMed ID: 23219791
[TBL] [Abstract][Full Text] [Related]
38. Induction of beige adipocytes by naturally occurring β3-adrenoceptor agonist p-synephrine.
Takagi M; Kimura K; Nakashima KI; Hirai T; Inoue M
Eur J Pharmacol; 2018 Oct; 836():67-74. PubMed ID: 30120922
[TBL] [Abstract][Full Text] [Related]
39. β3-adrenoceptor-mediated increased circulating transaminase levels in mice treated with its agonist BRL 37344.
Kasahara H; Muto S; Motokawa Y; Arisaka N; Kobayashi S; Souma S; Kuroda J
J Toxicol Sci; 2010 Oct; 35(5):779-84. PubMed ID: 20930473
[TBL] [Abstract][Full Text] [Related]
40. Preliminary evaluation of β3-adrenoceptor agonist-induced 18F-FDG metabolic activity of brown adipose tissue in obese Zucker rat.
Schade KN; Baranwal A; Liang C; Mirbolooki MR; Mukherjee J
Nucl Med Biol; 2015 Aug; 42(8):691-4. PubMed ID: 25934347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
